Upcoming poster presentation at AACR D3 features data supporting TP101 as a therapeutic strategy to target drug-resistant cancer stem cells Presented poster at AACR Special Conference on Breaking ...

AD/PD™, a leading international conference dedicated to advancing science and treatment strategies in neurodegenerative diseases, is inviting researchers, clinicians, and industry leaders worldwide to ...

AEPF2026 was honoured to welcome Conference Co-Chair Dr. Florence Lei, Coordinator of the Sustainable Business Lab and ...

The Japan Breast Cancer Research Group (JBCRG, based in Chuo-ku, Tokyo, Japan; Representative Director: Shigehira Saji) has established the YWBCH 2026 MedPro Publication Excellence Award, a new award ...

Bengaluru INDIA NANO 2026 puts AI and nanotechnology centre stage as Karnataka pushes deep-tech research from labs to markets.

Karnataka Chief Minister DK Shivakumar on Tuesday outlined an ambitious vision to transform Bengaluru from India''s ...

Cemsidomide’s Ongoing Phase 2 MOMENTUM Trial and Phase 1b Trial in Combination With Elranatamab Remain on Track to Deliver Clinical Data Readouts in 2027 ...

Company rapidly advancing toward Q1 2027 initiation of Phase 3 trials designed to deliver best-in-class efficacy with ...

Jaw-dropping patient videos and miraculous testimonials ignited a frenzy in China over a technique that aims to improve drainage from the brain. Now it is entering trials worldwide.

Operator: Good day and thank you for standing by. Welcome to the Biodesix Q2 2026 Earnings Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded. I would ...

Shionogi Inc., a New Jersey-based subsidiary of Shionogi & Co., Ltd., (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, PhD; hereinafter “Shionogi”) announced U.S. availability of ...

The last time I spoke about Immunome, Inc. (IMNM), it was with a Seeking Alpha article entitled “Immunome: Maintaining 'Strong Buy' On Successful RINGSIDE Trial With Varegacestat.” With respect to ...